Fem ale m ammals are born with a nite number of ovarian primordial follicles that cannot be regenerated; thus, chemicals that destroy oocytes contained in these follicles can produce prem ature ovarian failure (early menopuas e in women). Exposure of women to know n ovotoxican ts, such as contaminants in cigarette smoke, is associated with early menopause . Thus, the potential risks posed by ovotoxic chemicals is of concern. Our studies have focused on the environmental chemical 4-vinylcyclohexene (VCH), which is produced during the manufacture of rubber tires, ame retardants, insecticides, plasticizers, and antioxidants. Dosing of female rats and mice with the ovotoxic diepoxide metabolite of VCH, 4-vinylcyclohexene diepoxide (VCD), for 30 days destroye d the majority of ovarian primordial follicles. Using VCD in rats as a generalized mode l for ovotoxicity, we determined that 1) repeated daily dosing is required, 2) cell death is via apoptosis, and 3) altered expression of speci c genes is involved. An integrated approach at the morphologic, biochemical, and molecular level was used to support these conclusions. Studies in isolated rat small preantral follicles (targeted for VCD-induced ovotoxicit y) focused on the role of cell death genes, mitochondrion-associated events, and VCD metabolism. We also evaluated how this information relates to human risk for early menopause . These animal research results provide a better understand ing of the potential risk of human exposure to environmental ovarian toxicants and greater insight as to the impact of these toxicants on reproductive health in wom en.
INTRODUCTION

Ovarian Toxicity
Today, women are found in the workplace environment in record num bers. Many of these wom en are postponing childbearing to establish a career. For this reason and because people are exposed to ever-increasing com binations of environm ental chemicals, there is an increased awareness of the impact of environmental chemicals on reproductive health. More speci cally, a better understanding of the effect of reproductive toxicants on ovarian function is of particular importance because the ovary is critical to normal reproduction. Environm ental chemicals can affect ovarian function via destruction of oocyte-containing follicles (15, 24, 26) . Development and maturation of oocytes occur within ovarian follicles. Successful ovulation of the oocyte requires appropriate progression of the follicle through a num ber of distinct developmental stages (12, 37) . The most immature stage of follicular developm ent is the prim ordial stage, during which follicles are formed in the ovary during fetal development. The oocytes contained in these follicles are arrested in the rst meiotic division, and no more can be generated after birth (12) . Therefore, if something, such as exposure to environmental chem icals, causes widespread destruction of prim ordial follicles, the result is ovarian failure (early menopause in women) (15, 28) . Consequently, destruction of the population of smallest ovarian follicles (pri-mordial and primary) is of concern when agents are assessed for their potential to cause early m enopause.
4-Vinylcyclohexene and Ovotoxicity
Our studies have focused on the epoxide metabolites of 4-vinylcyclohexene (VCH), which have been shown to destroy oocytes contained in small preantral (primordial and primary) follicles in the ovaries of mice and rats (39 -41) . VCH is formed from the dim erization of 1,3butadiene in the manufacture of synthetic rubber, ame retardants, insecticides, plasticizers, and antioxidants; thus, there is potential for hum an exposure in the industrial setting (17) . The results of our early studies demonstrated a greater susceptibility of m ice than rats to these compounds. Although 30 days of intraperitoneal dosing with VCH produced ovarian follicle loss in mice but not in rats, dosing with the diepoxide m etabolite 4-vinylcyclohexene diepoxide (VCD) caused this loss in both species (40) . In a number of m etabolic and structure-function studies, it was determ ined that VCD is the ovotoxic form of the parent com pound VCH and that m ice have a signi cantly greater ability to bioactivate VCH than do rats (8, 14, 39 -41) . Consequently, mechanistic studies related to direct ovarian effects have utilized VCD. In designing our mechanistic studies, a variety of questions emerged. W hy are the smallest preantral follicles the apparent select targets for ovotoxicity? Are oocytes destroyed by necrosis or by a program med form of cell death (apoptosis)? Does the mechanism involve altered regulation of normal signal transduction pathways that lead to cell death? W hat is the intracellular target for induction of toxicity? W hat is the impact of dose and frequency? To begin to address these questions, an investigation of the mechanisms of cell death at the cellular level induced by VCD in rats was undertaken.
CELLULAR MECHANISMS OF OVOTOXICITY Cell Death
A role for VCD in producing extensive damage in small preantral follicles had been dem onstrated in 30-day dosing studies. However, because of the widespread loss of follicles at that time, detailed information related to induction of this toxicity could not be obtained. Because it was of interest to identify the follicle type(s) directly targeted by VCD and to determine the mechanism(s) by which ovotoxicity is produced at the cellular and m olecular level, the early events in ovotoxicity had to be characterized in detail.
Response to Dosing
Onset of Ovotoxicity. To determ ine the mechanism(s) by which VCD is ovotoxic in rats, it was necessary to identify the earliest time of repeated exposure that toxicity could be obser ved. Therefore, a time-course study (days 6-12 of dosing) was conducted and analyzed by morphologic evaluation (19) . Overall toxicity initiated by VCD was estimated on each day by making a combined assessment of the num ber of follicles lost plus the percentage of unhealthy follicles that remained, relative to controls. For this assessment, follicles were classi ed as primordial, primary, or growing. In the 30-day studies, signi cant loss of small follicles was observed in the primordial, primary, and growing stages. However, in the shorter study, reduced num bers of primordial and primary follicles were rst seen on dosing day 12, a time at which the number of growing follicles was unchanged. These ndings supported the hypothesis that prim ordial and prim ary follicles are directly targeted by VCD and that the loss of growing follicles seen on day 30 was the result of fewer smaller follicles from which to recruit. Evidence of impending VCD-dependent ovotoxicity was rst seen on dosing day 10 in primordial follicles. At that time, relative to controls, there was an increase (p 0.05) in percentage of unhealthy follicles, although no signicant follicle loss had yet occurred. The appearance of unhealthy follicles in response to VCD was similar to that of unhealthy control follicles undergoing atresia (42) . Therefore, the VCD -dependent effect on morphology could only be assessed as a greater percentage of unhealthy follicles than seen in control ovaries. This result provided evidence that VCD -induced ovotoxicity follows repeated dosing and occurs via the sam e physiological mechanism responsible for norm al atresia.
Atresia. The ultimate event associated with follicular destruction is cell death. In the m amm alian ovary, the number of primordial follicles present at birth that will ever be selected to ovulate is small (37) . Instead, the vast majority of follicles eventually undergo degeneration by a process known as atresia (12, 28) . Atresia in the rat occurs via a mechanism of programm ed cell death (apoptosis) (45) . Apoptosis occurs in many tissues and results in rem oval of unwanted cells by a nontraumatic mechanism (20) . Therefore, this form of cell death is ''silent,'' ie, it is physiologically undetected by the organism . This situation is in distinct contrast to cell death by necrosis, which usually occurs in response to injury and elicits an in ammatory response in the surrounding tissue. The original distinction between apoptosis and necrosis was based upon m orphologic characteristics (21) . Thus, a comparison of ultrastructural changes in small preantral follicles in control rats versus rats that were dosed daily with VCD (10 days) was m ade (Figure 1 ). The appearance of oocytes in unhealthy follicles in both groups of anim als was similar and included breakdown of organelles, increased numbers of vacuoles, accum ulation of m embrane components, and abnormal segmentation (cleavage) relative to oocytes in healthy follicles. Although these changes occur in the oocyte, surrounding support cells rem ain healthy at this time. Thus, the morphologic changes involved in degeneration of the oocyte during atresia are not altered by VCD treatm ent, but rather VCD enhances this process and atresia occurs with greater frequency.
Involvement of Bax. Although morphologic characterization is the most reliable method to distinguish between apoptosis and necrosis (34) , they can also be distinguished by biochem ical and molecular markers. One family of genes in mamm alian cells that has been speci cally associated with apoptosis is the bcl-2 fam ily of protooncogenes. Bcl-2 protein (and its homolog, Bcl-X long) have been localized to the outer mitochondrial m embrane, endoplasmic reticulum, and nuclear membrane and are associated with prolonged cell survival (13, 16, 47) . Another m ember of this gene fam ily, bax, shares significant sequence hom ology with bcl-2 but functions to promote apoptotsis. The ratio of Bax protein to Bcl protein in a cell probably determ ines its fate: apoptosis (increased ratio) versus sur vival (decreased ratio) (49) . The effect of 10 days of VCD dosing in rats on expression of mRNA encoding the cell death enhancer gene bax was examined (43) . Com pared with controls, VCD signicantly increased (by 72% , p 0.05) the amount of bax mRNA in isolated small follicles. These obser vations provided evidence for an involvement of the bcl-2 family of proto-oncogenes in VCD -induced ovotoxicity and provided further support for the hypothesis of cell death via apoptosis, the natural process of atresia.
Protective Effects. In time-course studies for the onset of VCD -induced ovotoxicity in rats, a single dose of VCD, unlike repeated dosing, caused a decrease in the percentage of unhealthy small follicles. This nding suggested an early protective effect of VCD dosing and prompted a more detailed investigation of this phenomenon. Twenty-four hours following a single dose of VCD in rats, the number of healthy follicles was greater than that seen in controls ( Figure 2 ). This effect was selective for primary follicles and persisted for 15 days (following only 1 dose), at which time a greater number of healthy primary follicles was still observed. This effect was in marked contrast to the decrease in num bers of healthy follicles in ovaries of rats given 15 daily doses of VCD. We concluded that 1) normal atresia in primordial and primary follicles mainly occurs in prim ary follicles, 2) an initial exposure to VCD protects against this atresia, and 3) ovotoxicity following repeated daily exposure results from an acceleration of the rate of norm al atresia (4) .
The rate of ovarian atresia is greatest in rats during the neonatal stage of life. With the onset of sexual maturity, this rate slows substantially, and the m ajor follicle population that displays atresia shifts from small preantral (prim ordial and primary) follicles to larger antral follicles (37) . Because this shift in atresia coincides with the onset of ovarian cyclicity, 17 -estradiol produced in large ovarian follicles may norm ally participate in slowing of the rate of atresia in preantral follicles at that time. In a series of experiments, the ability of 17 -estradiol to alter the VCD -accelerated rate of atresia was investigated (unpublished data; sum marized in Table 1 ). A protection against VCD -induced ovotoxicity (accelerated atresia) was provided by concurrent dosing with a pharm acologic dose of 17 -estradiol, and as with the protection provided by a single dose of VCD, this protection was seen specically in primary follicles. In support of an estrogen re-ceptor (ER)-mediated mechanism, this protection was mimicked by the ER agonist genistein and was prevented by concurrent dosing with the ER antagonist 4-hydro xy tam oxifen. The exact role of this estradiol-mediated effect is currently under investigation. These m orphologic and m echanistic data provide convincing support that VCD-induced ovotoxicity in rats occurs by accelerating the normal rate of atresia, cell death by apoptosis. Because norm al mechanism s that regulate atresia in preantral follicles are poorly understood, these data also provide physiological inform ation related to that process.
MOLECULAR MECHANISMS OF OVOTOXICITY
We demonstrated that follicular destruction in rat ovaries induced by VCD is selective for primordial and primary follicles and occurs only after repeated daily dosing with VCD.
Follicle Isolation
To better understand speci c mechanisms by which VCD produces such a selective destruction of oocytes, in vitro studies with ovarian tissue were required. The dynam ic heterogeneity of the ovary has been well documented (12, 37) . Primordial and primary follicles are the smallest and most immature structures and are thought to be relatively inactive. Because these cells are the physiologic targets of VCD, biochemical and molecular measurem ents made from tissue preparations of whole ovaries (also containing many larger structures) would obscure speci c measurem ents in those smallest ovarian com partm ents. Therefore, a technique for isolation of highly puri ed fractions of small preantral follicles has been developed using gentle dissociation with collagenase (9) . Following dissociation, intact follicles are recovered and can be hand-sorted with micropipets into 2 preantral fractions: fraction 1 (25-100 m diameter), containing primordial, primary, and early growing follicles, and fraction 2 (100 -250 m diameter), containing larger grow in g, n ontarg eted p reantral follicles. T his method also provides a nontargeted follicle fraction to use as a point of comparison. In most experiments, liver tissue is prepared to provide an additional nontarget tissue that may be metabolically involved in the response to VCD.
Ovarian Metabolism
Much evidence has been gathered to indicate that bioactivation of VCH in mice to the ovotoxic form, VCD, can occur in the liver (41) . As yet, the potential role of the ovary in metabolism of VCH and/or VCD has not been thoroughly investigated. The ovary contains enzymes responsible for biotransformation and detoxi cation of many xenobiotics. Both the rat and mouse ovar y contain epoxide hydrolase, glutathione S-transferases, and cytochrom e P-450, which metabolize known ovarian toxicants including VCH and VCD (2, 10, 29, 31, 32) . Metabolism of a chemical within the ovar y might occur within selected structures, causing a com partm entalization of exposure to toxicity within certain classes of follicles. The major enzymatic pathways for detoxi cation of xenobiotic epoxides are hydration to corresponding diols (catalyzed by microsom al epoxide hydrolase) and conjugation with glutathione (catalyzed by glutathione Stransferase). Both m icrosomal epoxide hydrolase and cytosolic glutathione S-transferase, which probably are involved in metabolism of VCD, are expressed in the ovar y (2, 31, 32) . However, no studies have been reported by others as to whether those phase II metabolic enzymes are speci cally expressed in small preantral follicles. Using isolated ovarian small preantral follicles from rats, experim ents were performed to identify the direct ability of ovarian cells to metabolize (detoxify) VCD (Figure 3 ) (9). Following in vitro incubation, the smallest follicles (fraction 1) displayed a lower capacity to convert VCD to the tetrol than did larger preantral follicles (fraction 2). These results provided evidence that the rat ovar y can directly detoxify VCD to the inactive tetrol 4-(1,2dihyd roxy )ethyl -1 ,2 -dihyd roxy cycloh exane, bu t the smallest follicles that are the physiologic target of VCDinduced ovotoxicity have a lower capacity for detoxication.
Mitochondrial Involvement
Our molecular studies have provided evidence for the mitochondrion as a site of involvement in VCD -induced ovotoxicity in small follicles. Responses in several genes generally associated with m itochondrial effects have been shown.
Manganese Superoxide Dismutase. Several antioxidant scavenging enzym es are present in the cell: superoxide dism utase (SOD), glutathione peroxidase, and catalase. Collectively, these molecules are referred to as the oxidative stress response enzymes because they protect the cell from the damaging effects of reactive oxygen species and apoptosis (5) . Additionally, there are 3 isoforms of SOD that vary by intracellular localization. The manganese (Mn) isoform is associated with mitochondria, the copper/zinc (Cu/Zn) form is associated with the cytosol, and the secreted (Sec) form is secreted to the extracellular space (30) . In a recent study, the role of oxidative stress in large antral follicles in the rat was examined (46) . Expression of mRNA encoding oxidative stress genes under conditions of inhibited atresia (apoptosis) was increased for M nSOD and SecSOD but was unchanged for Cu/ZnSOD, glutathione peroxidase, and catalase. These results suggested that MnSOD m ay be important in protecting ovarian follicles from atresia. W hether the oxidative stress genes are expressed in small preantral follicles had not been investigated. The effect of VCD dosing for 10 days on mRNA levels for the 3 forms of SOD was measured in isolated small follicles (43) . Compared with controls, VCD caused a 148% increase in MnSOD m RNA levels in fraction 1 follicles (Figure 4) . Conversely, in larger follicles and liver there was no VCD -induced effect. Additionally, there was also no change in mRNA levels for Cu/ZnSOD or SecSOD in any tissue fraction as a result of VCD dosing. Thus, 0.65* a Rats were dosed daily for 15 days with vehicle control or VCD (80 mg/kg intraperitoneally). Ovaries were collected, and small (fraction 1) follicles were isolated for analysis (9) . b VCD/control values determined by reverse transcription polymerase chain reaction (4) .
c Fluorescence intensity measured in confocal micrograp h image using rat-speci c cytochrom e c primar y antibody, visualized by Cy5 immuno uorescence staining. d VCD/control values determined by uorescence intensity of AMC cleaved from Ac-DEVD-AMC by caspase-3.
* p 0.05 compared with control; n 3.
VCD led to increased mRNA levels for M nSOD, specifically in small VCD -targeted follicles. Furthermore, this increase was seen at the earliest tim e of impending VCDinduced follicle dam age, a time (day 10) at which follicle loss has not yet occurred (19, 42) . In a follow -up observation, m RNA levels for MnSOD had returned to control levels by day 15 of dosing with VCD (unpublished data). Therefore, the conclusions to be drawn from this study are that the increased MnSOD mRNA levels in follicles from VCD -treated rats are related to an early but ultimately futile attem pt in small follicles to counteract an increase in oxidative stress. Bax Expression. Bax protein is another gene product with a mitochondrial m embrane site of action (48) . A determ ination was m ade of the effect of VCD on relative levels of m RNA for bax in small follicles isolated from rats dosed for 15 days ( Table 2 ). The increase had previously been shown to be speci c for VCD -targeted fraction 1 follicles isolated from rats dosed for 10 days with VCD (43) . Relative to day 10 of dosing (72% above control levels), expression of bax mRNA in small follicles was increased even more (238% above control levels) in response to 15 days of dosing. The VCD -dependent increase in bax mRNA suggests that expression of Bax protein is also increased. Bax protein is involved in enhancing apoptosis via its interaction with the mitochondrial m embrane. In that capacity, it causes alterations in membrane potential and a resulting disruption of mitochondrial function (33) . Therefore, increased expression of bax speci cally in small follicles (targets of VCDinduced ovotoxicity) is consistent with intracellular involvement of m itochondria in VCD-induced atresia (apoptosis).
Cytochrome c Leakage. Upon Bax-induced disruption of the mitochondrial m embrane, resulting cellular damage that can occur includes leakage of cytochrome c protein into the cytosolic compartment (22) . W hen ovaries collected from VCD-dosed rats were analyzed by confocal microscopy using immunohistochemistry, there was a reduction in the number of follicles that displayed mitochondrion-associated staining of cytochrome c when compared with controls ( Table 2 ). This reduction was visualized (and quanti ed by analysis of staining intensity) as a shift in staining from punctate (higher intensity, localized within m itochondria) to diffuse (lower intensity, dispersed into the cytoplasm). Total cellular protein levels of cytochrome c in small follicles (determined by western blotting) were unaffected by VCD, although there was a shift from mitochondrial to cytosolic localization (unpublished observation). Therefore, the reduced intensity of staining in VCD -treated animals was due to leakage of cytochrome c into the cytosol rather than degradation of the protein. This nding provides further support for a Bax-mediated m echanism of induction of apoptosis by VCD via mitochondrial targeting. The cytochrome c effect was seen speci cally in primary follicles, those follicles protected from VCD-induced atresia by a single dose of VCD (Figure 1) or by 17-estradiol dosing (Table 1).
Caspase-3 Activation. In many cell types, activation of a proteolytic enzyme, caspase 3, occurs in the cytosol during induction of apoptosis (1). This activation can result from several upstream events, one of which is disruption of m itochondria. As a result, activation (proteolytic clipping) of procaspase 3 can be initiated by cytochrom e c that has been released from its mitochondrial stores (23) . Relative to controls, an increase in caspase-3 activity in isolated small follicles collected from rats dosed for 15 days with VCD was observed. This observation further implicates this pathway of enhancement of apoptosis by VCD ( Table 2 ). These data provide support for a m itochondrial site of targeting during VCD -induced ovotoxicity in small follicles, and the mechanism of activation of the apoptotic pathway appears to involve, Bax, cytochrome c, and caspase 3. The focus of our mechanistic studies is now on upstream events that initiate the Bax-induced cascade.
OVOTOXICITY AND M ENOPAUSE
Relevance to Humans
W hen the ovaries in wom en are depleted of prim ordial follicles, the result is menopause. Because the ovary contains a nite number of oocytes at birth, hum an exposure to environmental chemicals that destroy primordial follicles can cause early menopause. Wom en smokers suffer from infertility and are known to undergo early menopause (25, 27) . Several polycyclic arom atic hydrocarbons (PAHs) that are ovotoxic and found in cigarette smoke include 9,10-dim ethylbenzanthracene (DMBA), 3-m ethylcholanthrene (3-MC), and benzo[a]pyrene (BaP) (15, 25, 44) . Because these PAHs are known to dam age primordial and primary follicles in m ice and rats, it is possible that they contribute to the early menopause seen in women exposed to cigarette smoke (prim ary or second hand) (27) . In wom en smokers, prior to early m enopause dam age to larger follicles (secondary through antral) caused by exposure to PAHs could also cause problem s with fertility. Secondary follicles in laborator y animals are also sensitive to PAHs (3, 24) . Thus, these chem icals may also contribute to the infertility reported in women smokers. This information indicates links between the effects of exposures in women and those in animals. Therefore, information obtained from anim al studies may be VCD-INDUCED OVOTOXICITY useful for planning epidemiologic investigations into potential reproductive effects resulting from exposure of wom en to ovotoxic chemicals.
PAHs and VCD, a Comparison
As a result of the connection between smoking and early menopause (18) , the effects of PAHs on the ovar y have been studied. A study was undertaken to com pare ovotoxicities in female B6C3F 1 mice and Fischer 344 rats using the PAHs DM BA, 3-M C, and BaP. A method for comparing the relative toxicities of these PAHs with that caused by VCD was developed by generating an ovotoxic index (OI) for these chemicals (3) . This method can be modi ed to evaluate a variety of param eters (types of follicles targeted, earliest onset of ovotoxicity, susceptibilities by age or species) and can be used to determine a relative rank of toxicities for these chemicals. In 1 study (3), the OI was calculated from the dose of each of the 3 PAHs that produced a 50% loss of prim ordial follicles after 15 days of dosing (p 0.05; ED 50 ). These values were used to calculate an OI in mice and rats (OI ED 50 15 doses). Thus, a chemical with a lower OI is more toxic. The OIs were then used to determine which preantral follicle populations in mice and rats are most susceptible to the ovotoxic effects of the PAHs as compared with the effects of VCD. In general, with the PAHs primordial follicles were more susceptible (lower OI) to ovotoxicity in mice, whereas secondary follicles were mainly targeted in rats. Additionally, the mouse was m ost susceptible to DM BA (OI 0.0012), whereas the rat was most susceptible to 3-M C (OI 0.004). All three PAHs were more ovotoxic than VCD (OI 8.6).
Type of Exposure
In evaluating ovotoxicity caused by environmental chemicals, the level of exposure required to produce ovarian damage in anim als is particularly important. Only under rare, accidental circumstances are large groups of wom en acutely exposed to high levels of reproductive toxicants, and the effects of these exposures can usually be detected and evaluated. However, the potential effects of chronic exposure to low levels of reproductive toxicants are m ore dif cult to determine because of the potential for additive or cum ulative effects (15) . As a result, fertility problems produced by environmental exposures may go unrecognized for years but could manifest as early menopause. Our demonstration that oocyte loss produced by VCD is by apoptosis, a ''silent'' m echanism of ovotoxicity, supports this possibility.
Previous studies in mice and rats involved examination of ovotoxic effects caused by a single high dose of PAHs (29) ; however, chronic exposure to low doses is more likely in wom en. To determine the role of the exposure paradigm in ovotoxicity, a com parison was made between low -dose repeated exposures (15 doses) and single high-dose exposures to the 3 PAHs in B6 m ice. The single-dose OIs were calculated from results previously reported: 50% of primordial and primary follicles was lost within 1-2 days (29) . By comparison, for all 3 PAHs the OIs calculated from repeated low -dose exposures that produced 50% ovotoxicity in primordial follicles in our studies were lower (indicating higher toxicity) than those from a single high dose (3) . That is, the OI (ED 50 15 doses) for repeated low -dose exposure was 258-fold lower (indicating higher toxicity) for DMBA (0.0012 vs 0.3100), 100-fold lower for 3-MC (0.0030 vs 0.3000), and 1.7-fold lower for BaP (0.1800 vs 0.3200) when compared with the single high-dose OIs (ED 50 1 dose).
There may be several reasons that differences in ovotoxicity are seen between high-and low -dose exposures. First, a variety of studies with xenobiotics have indicated a relationship involving the dose of a chemical, the duration of exposure, and the type of cell death that follows. Low doses induce apoptosis, whereas higher doses often cause necrosis (6, 7, 11, 35, 36, 38) . Thus, mechanisms of cellular dam age in response to xenobiotics appear to differ as a function of dose. In 1 study (24) , the ovotoxic effects of 3 PAHs (DM BA, 3-M C, and BaP) given as single high doses (80 m g/kg) were described as morphologic changes in prim ordial follicles that were m ore consistent with necrosis than with apoptosis, whereas follicular dam age caused by low doses was more consistent with apoptosis (3). Second, a single dose of VCD in rats was protective against the normal rate of atresia (follicle loss by apoptosis) (4). This nding was in marked contrast to the VCD -induced increase in atresia seen 15 days after repeated daily dosing. Thus, ovarian defense m echanisms in response to low doses of ovotoxic chemicals may initially be induced but may ultim ately fail after experiencing repeated attack. Exposure to a single high dose of an ovotoxicant would preclude activation of these defenses. The results demonstrate that repeated low-dose exposures can be substantially more toxic to the ovar y than a single high-dose exposure. This nding is particularly important in view of the implications for chronic low -dose exposures of women to environmental chemicals.
DISCUSSION
In recent years, there has been an increase in the investigation of apoptotic cell death following treatm ent with toxic chemicals (7) . However, little is known about the types of cell death induced by reproductive toxicants in the ovary. The data discussed here provide insight into the mechanism(s) by which VCD is ovotoxic to prim ordial and prim ary follicles in rats. This m echanism 1) involves acceleration of the normal rate of atresia, 2) results from intracellular targeting of mitochondrion-m ediated pathways of apoptosis, and 3) requires repeated exposure. A comparison of the effects VCD dosing and PAH dosing revealed that PAHs induce ovotoxicity at substantially lower concentrations (lower OI) and are thus more ovotoxic. The ovotoxicity seen with PAHs also dem onstrated that repeated low -dose exposures are potentially more damaging than exposure to a single high dose. Thus, further studies should be focused on the potential risk in wom en chronically exposed to low levels of ovarian toxicants. In addition to the chemicals discussed here, other types of xenobiotic compounds are also known to destroy prim ordial and primary follicles in laboratory animals (15) . Large numbers of wom en probably have been exposed on a long-term basis to 1 or a combination of these ovotoxic chemicals. Therefore, the greater risk for premature m enopause for wom en exposed to a variety of environm ental factors is real. Future research should be directed toward characterization of hum an exposures and identi cation of cellular/molecular mechanisms of ovotoxicity in animals. The information generated can then be used to evaluate the potential risk for women exposed to these types of environmental chem icals.
